Healthcare

GLP 1 therapies have redefined what obesity pharmacotherapy can achieve, but efficacy is no longer the only battleground.

Football, Pride, Digital Twins… Ipsos Update explores the latest research and thinking on key topics from Ipsos teams around the world.

What Patients Need Next and Who Will Deliver It

In this Ipsos Point of View, discover how to harness AI's speed without falling into the confidence trap.

Conducted monthly in 30 countries among around 20,000 adults for over a decade, the Ipsos What Worries the World study offers an exceptional snapshot of world opinion on pressing global issues.

Longevity medicine is changing physician-patient dynamics. Download our framework for healthcare professionals navigating new patient expectations and structural barriers.

How Chinese Biopharma Innovation is Forging the Future of Global Oncology Deal Making.

For those who couln't join, and are keen to access key insights, can join us on April 2nd where we’ll share the most important learnings from the event, including highlights from the Ipsos I&O Food & Health Study.

New global syndicated survey highlights a striking contradiction at the heart of how obesity is understood, especially by those living with it.